Literature DB >> 10844713

Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease.

R Brookmeyer1, S Gray.   

Abstract

Projections of the incidence and prevalence of disease are important for public health planning. This paper describes methods for projecting the incidence and prevalence of a chronic disease in ageing populations. The approach uses age-specific disease incidence rates together with assumptions about survival to reconstruct disease prevalence. The methods can be used to evaluate the potential impact of public health interventions that may prevent disease or prolong survival. We used the methods to project the future prevalence of Alzheimer's disease in the United States. We found that the prevalence of Alzheimer's disease will nearly quadruple over the next 50 years. Although projections of the absolute prevalence are sensitive to assumptions about the age-specific incidence rates of disease, the proportionate growth is relatively insensitive. The increase in prevalence results from the ageing of the U.S. population. In order to perform the calculations, we have assembled U.S. Census population projections and U.S. mortality rates into computer software that is available from the authors at www.jhsph.edu/Departments/Biostats/software.h tml. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10844713     DOI: 10.1002/(sici)1097-0258(20000615/30)19:11/12<1481::aid-sim440>3.0.co;2-u

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  26 in total

1.  Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

2.  Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.

Authors:  Takashi Mori; Naoki Koyama; Tatsuya Segawa; Masahiro Maeda; Nobuhiro Maruyama; Noriaki Kinoshita; Huayan Hou; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

3.  Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project.

Authors:  Yuriko Katsumata; Hidemi Todoriki; Yasushi Higashiuesato; Shotoku Yasura; D Craig Willcox; Yusuke Ohya; Bradley J Willcox; Hiroko H Dodge
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-20       Impact factor: 6.053

4.  How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050.

Authors:  T Mura; J-F Dartigues; C Berr
Journal:  Eur J Neurol       Date:  2009-10-01       Impact factor: 6.089

5.  Paid caregiver motivation, work conditions, and falls among senior clients.

Authors:  Lee A Lindquist; Karen Tam; Elisha Friesema; Gary J Martin
Journal:  Arch Gerontol Geriatr       Date:  2012-02-22       Impact factor: 3.250

Review 6.  A review of multidomain interventions to support healthy cognitive ageing.

Authors:  N Schneider; C Yvon
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

Review 7.  Progress in gene therapy for neurological disorders.

Authors:  Michele Simonato; Jean Bennett; Nicholas M Boulis; Maria G Castro; David J Fink; William F Goins; Steven J Gray; Pedro R Lowenstein; Luk H Vandenberghe; Thomas J Wilson; John H Wolfe; Joseph C Glorioso
Journal:  Nat Rev Neurol       Date:  2013-04-23       Impact factor: 42.937

Review 8.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

9.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

10.  A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.

Authors:  Mary Sano; Diane Jacobs; Howard Andrews; Karen Bell; Neill Graff-Radford; John Lucas; Peter Rabins; Karen Bolla; Wei-Yan Tsai; Peter Cross; Karen Andrews; Rosann Costa
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.